U.S. federal trademark · Serial No. 99148564
Pharmaceutical preparations for the treatment of mitochondrial diseases, namely, primary and secondary mitochondrial diseases; Pharmaceutical preparations for the treatment of diseases and conditions with mitochondrial dysfunction, namely, altered redox status, increased reactive oxygen species, and inflammation
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.